A detailed history of Banco Santander, S.A. transactions in Amgen Inc stock. As of the latest transaction made, Banco Santander, S.A. holds 83,860 shares of AMGN stock, worth $26.5 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
83,860
Previous 92,517 9.36%
Holding current value
$26.5 Million
Previous $26.3 Million 0.39%
% of portfolio
0.32%
Previous 0.32%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$262.75 - $319.31 $2.27 Million - $2.76 Million
-8,657 Reduced 9.36%
83,860 $26.2 Million
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $8.64 Million - $10.4 Million
-32,140 Reduced 25.78%
92,517 $26.3 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $1.26 Million - $1.42 Million
-4,920 Reduced 3.8%
124,657 $35.9 Million
Q3 2023

Nov 08, 2023

BUY
$218.65 - $271.46 $1.85 Million - $2.29 Million
8,440 Added 6.97%
129,577 $34.8 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $9.75 Million - $11.5 Million
45,511 Added 60.18%
121,137 $26.9 Million
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $74,510 - $90,816
-330 Reduced 0.43%
75,626 $18.3 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $170,398 - $216,511
-744 Reduced 0.97%
75,956 $19.9 Million
Q3 2022

Nov 08, 2022

SELL
$224.46 - $253.15 $2.57 Million - $2.9 Million
-11,460 Reduced 13.0%
76,700 $17.3 Million
Q2 2022

Jul 28, 2022

BUY
$230.71 - $256.74 $1.95 Million - $2.17 Million
8,451 Added 10.6%
88,160 $21.4 Million
Q1 2022

May 09, 2022

SELL
$219.27 - $242.57 $26,531 - $29,350
-121 Reduced 0.15%
79,709 $19.3 Million
Q4 2021

Feb 09, 2022

BUY
$198.88 - $227.6 $870,895 - $996,660
4,379 Added 5.8%
79,830 $18 Million
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $426,662 - $499,887
2,010 Added 2.74%
75,451 $16 Million
Q2 2021

Jul 29, 2021

BUY
$233.58 - $259.14 $1.35 Million - $1.49 Million
5,768 Added 8.52%
73,441 $17.9 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $2.14 Million - $2.54 Million
-9,871 Reduced 12.73%
67,673 $15.6 Million
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $17.9 Million - $19.9 Million
76,194 Added 5644.0%
77,544 $19.7 Million
Q2 2020

Aug 05, 2020

SELL
$197.81 - $242.74 $1.65 Million - $2.02 Million
-8,319 Reduced 86.04%
1,350 $318,000
Q1 2020

May 11, 2020

BUY
$182.24 - $241.7 $165,291 - $219,221
907 Added 10.35%
9,669 $1.96 Million
Q4 2019

Feb 07, 2020

BUY
$189.21 - $243.2 $22,705 - $29,184
120 Added 1.39%
8,762 $2.11 Million
Q3 2019

Nov 06, 2019

SELL
$174.11 - $208.62 $721,685 - $864,729
-4,145 Reduced 32.42%
8,642 $1.68 Million
Q2 2019

Aug 07, 2019

SELL
$166.7 - $195.41 $176,368 - $206,743
-1,058 Reduced 7.64%
12,787 $2.36 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $79,582 - $89,707
440 Added 3.28%
13,845 $2.63 Million
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $26,938 - $31,445
151 Added 1.14%
13,405 $2.61 Million
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $872,160 - $983,245
4,707 Added 55.07%
13,254 $2.75 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $386,066 - $433,635
2,325 Added 37.37%
8,547 $1.58 Million
Q1 2018

May 14, 2018

BUY
$169.43 - $198.0 $1.05 Million - $1.23 Million
6,222 New
6,222 $1.06 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Banco Santander, S.A. Portfolio

Follow Banco Santander, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.